Global Biomarker Technologies Market

Biomarker Technologies Market Size, Share, Growth Analysis, By Product(consumables (reagents and assays), instruments, and services), By technology(polymerase chain reaction, next generation sequencing, immunoassays, and others), By Application(drug discovery, diagnostics, and personalized medicine), By Indication(cancer, infectious diseases, autoimmune disorders, cardiovascular disorders), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2220 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 120 |Figures: 77

Biomarker Technologies Market Insights

Biomarker Technologies Market size was valued at USD 31.5 billion in 2022 and is poised to grow from USD 34.40 billion in 2023 to USD 63.69 billion by 2030, at a CAGR of 9.2% during the forecast period (2023-2030).

The global biomarker technologies market plays a crucial role in the field of healthcare by utilizing biological characteristics to assess normal and pathological processes, as well as therapeutic responses. Biomarkers are identified through various technologies such as polymerase chain reaction, next-generation sequencing, and immunoassay.

They are extensively used for diagnosing diseases like cancer, infectious diseases, and autoimmune disorders, as they mark biological changes associated with these conditions. Biomarkers also aid in the early detection of drug toxicity during the drug development process and provide valuable data for personalized medicine.

The market is expected to experience significant growth due to the increasing prevalence of diseases, growing research and development activities in healthcare, and the adoption of early toxicity testing.

However, challenges such as high initial investments for biomarker discovery and limited awareness regarding biomarker technologies hinder market growth. Nonetheless, emerging economies offer promising opportunities for the biomarker technologies market's expansion in the future.

US Biomarker Technologies Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 31.5 billion

Largest Segment

consumables

Fastest Growth

consumables

Growth Rate

9.2% CAGR

Biomarker Technologies market by region
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Biomarker Technologies Market Segmental Analysis

The biomarker technologies market is segmented based on product, technology, application, indication, and region. In terms of product and service, it is divided into consumables (reagents and assays), instruments, and services. The market's technology segment includes polymerase chain reaction, next generation sequencing, immunoassays, and others. Application-wise, it is classified into drug discovery, diagnostics, and personalized medicine. Indication categories comprise cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. This comprehensive segmentation provides a detailed assessment of the biomarker technologies market and its various aspects in a concise paragraph.

Biomarker Technologies Market Analysis By Product

The largest segment is often the consumables category. Consumables such as reagents and assays are essential components in biomarker analysis and testing processes. They are regularly used and require replenishment, contributing to a steady demand for these products. The consumables segment also benefits from the continuous development of new biomarker assays and reagents, driving market growth.

On the other hand, the instruments segment represents the fastest-growing segment in the biomarker technologies market. Advances in technology have led to the development of sophisticated and high-performance instruments for biomarker analysis, such as PCR machines, next-generation sequencing systems, and immunoassay platforms. These instruments offer enhanced sensitivity, accuracy, and throughput, enabling researchers and clinicians to achieve more precise biomarker measurements. The increasing adoption of these advanced instruments in research laboratories, diagnostic centers, and pharmaceutical companies contributes to the rapid growth of the instruments segment in the biomarker technologies market.

Analysis By Technology

PCR-based biomarker technologies have gained significant prominence due to their versatility and widespread applications. PCR allows for the detection and quantification of specific DNA or RNA sequences, enabling researchers and clinicians to identify and analyze biomarkers associated with various diseases and conditions. PCR-based biomarker technologies have found extensive use in diagnostic applications, particularly in the field of infectious diseases and genetic testing. The ability of PCR to provide highly sensitive and specific results has contributed to its dominance in these areas. Moreover, advancements in PCR techniques, such as real-time PCR and digital PCR, have further expanded its utility and market penetration.

As for the fastest growing segment, PCR-based biomarker technologies continue to witness rapid growth due to ongoing technological advancements, increasing demand for personalized medicine, and the rising prevalence of chronic diseases. The integration of PCR with other technologies, such as next-generation sequencing and microarrays, has further propelled its growth by enabling high-throughput analysis and multiplexing capabilities.

Biomarker Technologies Market Analysis by Application

Diagnostics is the largest application segment in the biomarker technologies market. Biomarkers have significant utility in the early detection, diagnosis, and monitoring of various diseases. The growing emphasis on personalized medicine and targeted therapies has further propelled the demand for biomarker-based diagnostics. Biomarker tests are widely used for cancer screening, infectious disease diagnosis, cardiovascular risk assessment, and other clinical applications.

Personalized medicine is the fastest-growing application segment in the biomarker technologies market. Personalized medicine aims to tailor medical treatments to individual patients based on their unique genetic makeup and biomarker profiles. Biomarkers play a vital role in identifying patient-specific treatment approaches, optimizing drug selection, and monitoring therapeutic response. The advancements in genomics, proteomics, and molecular diagnostics have significantly contributed to the growth of personalized medicine and the demand for biomarker technologies.

Biomarker Technologies Market Analysis by Indication

The biomarker technologies market is segmented by indication into several categories, including cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others. Among these indications, cancer holds a significant share in the biomarker technologies market due to the rising prevalence of cancer globally and the growing demand for early and accurate cancer diagnosis. Biomarkers play a crucial role in cancer detection, prognosis, and monitoring of treatment response, driving the market growth in this indication.

In terms of the fastest growing indication, infectious diseases are expected to witness rapid growth in the biomarker technologies market. The ongoing COVID-19 pandemic has highlighted the importance of biomarkers in infectious disease diagnosis and management. The development of biomarker-based tests for COVID-19 detection and monitoring has accelerated the demand for biomarker technologies in this field. Additionally, the increasing incidence of other infectious diseases, such as HIV, hepatitis, and tuberculosis, further contributes to the growth of biomarker technologies in this indication.

Biomarker Technologies market by Application, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Biomarker Technologies Market Regional Insights

North America holds a significant share in the biomarker technologies market. The United States has a robust healthcare infrastructure and a strong presence of key market players. The region's advanced research and development activities, favorable government initiatives, and high healthcare expenditure contribute to its dominance in the market.

Europe is another prominent market for biomarker technologies. Countries such as Germany, France, and the UK have well-established healthcare systems and a strong focus on research and development. The presence of leading pharmaceutical and biotechnology companies in the region further drives market growth. Additionally, favorable reimbursement policies and increasing investments in precision medicine contribute to the market's expansion.

Biomarker Technologies market by region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Biomarker Technologies Market Dynamics

Increasing Demand for Personalized Medicine

  • Biomarker technologies play a crucial role in personalized medicine by aiding in the identification and monitoring of specific biomarkers related to an individual's health condition. The growing preference for targeted therapies and precision medicine approaches drives the demand for biomarker technologies.
  • The global burden of chronic and infectious diseases is increasing, leading to a greater need for accurate and early diagnostic methods. Biomarker technologies offer the potential for early disease detection, risk assessment, and monitoring of treatment response, thus driving their adoption in the healthcare industry.
  • The advancements in genomic research, particularly in the field of next-generation sequencing (NGS), have significantly contributed to the development of biomarker technologies. NGS enables the identification and analysis of genetic variations and biomarkers associated with diseases, leading to improved diagnostic accuracy and treatment selection.

High Cost of Biomarker Development and Validation

  • The development and validation of biomarkers require significant investments in research and clinical trials. The high costs associated with biomarker discovery, validation, and regulatory approvals pose a challenge, particularly for small and medium-sized companies, hindering their widespread adoption.
  • The regulatory landscape for biomarker technologies is complex and varies across different regions. Obtaining regulatory approvals and complying with the necessary standards can be time-consuming and challenging, which can impede the market growth and limit the availability of biomarker-based diagnostic tests and treatments.
  • The use of biomarker technologies raises ethical and legal concerns related to privacy, data protection, and informed consent. Issues surrounding the ownership and commercialization of biomarker data, as well as the potential for misuse or discrimination based on genetic information, can create barriers to the widespread adoption of biomarker technologies.

Request Free Customization of this report to help us to meet your business objectives.

Biomarker Technologies Market Competitive Landscape

The biomarker technologies market is highly competitive, with several key players vying for market share. These players focus on strategies such as mergers and acquisitions, partnerships, collaborations, and product launches to strengthen their market position. Leading companies in the market include Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Siemens Healthineers, Agilent Technologies, Qiagen N.V., PerkinElmer, Inc., Illumina, Inc., Abbott Laboratories, and Merck KGaA. These companies have a wide range of product portfolios, including consumables, instruments, and services, catering to various applications and indications. To stay competitive, companies invest heavily in research and development activities to develop innovative biomarker technologies and expand their product offerings. They also focus on expanding their geographic presence through strategic partnerships and collaborations with regional players. With the increasing demand for personalized medicine and precision diagnostics, the biomarker technologies market is expected to witness intense competition, driving companies to continually innovate and enhance their market position.

Biomarker Technologies Market Top Player’s Company Profiles

  • Bio-Rad Laboratories, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Illumina, Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • Abbott Laboratories (United States)
  • Siemens Healthineers AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Merck KGaA (Germany)
  • Bio-Techne Corporation (United States)
  • BD (Becton, Dickinson and Company) (United States)
  • Myriad Genetics, Inc. (United States)
  • Hologic, Inc. (United States)
  • Bruker Corporation (United States)
  • Agendia N.V. (Netherlands)
  • Pacific Biosciences of California, Inc. (United States)
  • Genomic Health, Inc. (United States)
  • Luminex Corporation (United States)

Biomarker Technologies Market Recent Developments

  • In May 2021, QIAGEN N.V., based in the Netherlands, launched the therascreen KRAS RGQ PCR Kit, which became the first tissue companion diagnostic approved by the FDA. This diagnostic kit is designed to identify the KRAS G12C mutation in NSCLC (non-small cell lung cancer) tumors. Its approval expands the options for precision medicine, enabling more targeted and personalized treatment approaches for patients.

Biomarker Technologies Key Market Trends

  • The biomarker technologies market is experiencing several key trends that are shaping its growth and development. Firstly, there is a growing emphasis on personalized medicine, with biomarkers playing a crucial role in identifying and monitoring specific disease biomarkers in individual patients. This trend is driven by advancements in genomics, proteomics, and molecular diagnostics, enabling the identification of unique biomarkers for precise disease diagnosis, prognosis, and treatment selection. Secondly, there is an increasing focus on non-invasive and minimally invasive biomarker testing methods, such as liquid biopsies, to reduce patient discomfort and improve diagnostic accuracy.

Biomarker Technologies Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the future of the biomarker technologies market appears promising, with several key trends driving its growth. Advancements in genomics, proteomics, and bioinformatics are enhancing biomarker discovery and validation, leading to the development of more accurate and specific biomarker assays. The increasing adoption of personalized medicine and targeted therapies, coupled with a growing emphasis on early disease detection and prevention, is fuelling the demand for biomarker technologies. Additionally, the integration of artificial intelligence and machine learning in biomarker research and diagnostics is expected to revolutionize the field, enabling more precise and efficient disease diagnosis, prognosis, and therapeutic monitoring. Overall, the biomarker technologies market is poised for significant advancements and expanded applications in the coming years.

Report Metric Details
Market size value in 2023 USD 31.5 billion
Market size value in 2031 USD 63.69 billion
Growth Rate 9.2%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • consumables (reagents and assays), instruments, and services
  • technology
    • polymerase chain reaction, next generation sequencing, immunoassays, and others
  • Application
    • drug discovery, diagnostics, and personalized medicine
  • Indication
    • cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Bio-Rad Laboratories, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Illumina, Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • Abbott Laboratories (United States)
  • Siemens Healthineers AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Merck KGaA (Germany)
  • Bio-Techne Corporation (United States)
  • BD (Becton, Dickinson and Company) (United States)
  • Myriad Genetics, Inc. (United States)
  • Hologic, Inc. (United States)
  • Bruker Corporation (United States)
  • Agendia N.V. (Netherlands)
  • Pacific Biosciences of California, Inc. (United States)
  • Genomic Health, Inc. (United States)
  • Luminex Corporation (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Biomarker Technologies Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Biomarker Technologies Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Biomarker Technologies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biomarker Technologies Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biomarker Technologies Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Biomarker Technologies Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Biomarker Technologies Market size was valued at USD 31.5 billion in 2022 and is poised to grow from USD 34.40 billion in 2023 to USD 63.69 billion by 2030, at a CAGR of 9.2% during the forecast period (2023-2030).

The biomarker technologies market is highly competitive, with several key players vying for market share. These players focus on strategies such as mergers and acquisitions, partnerships, collaborations, and product launches to strengthen their market position. Leading companies in the market include Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Siemens Healthineers, Agilent Technologies, Qiagen N.V., PerkinElmer, Inc., Illumina, Inc., Abbott Laboratories, and Merck KGaA. These companies have a wide range of product portfolios, including consumables, instruments, and services, catering to various applications and indications. To stay competitive, companies invest heavily in research and development activities to develop innovative biomarker technologies and expand their product offerings. They also focus on expanding their geographic presence through strategic partnerships and collaborations with regional players. With the increasing demand for personalized medicine and precision diagnostics, the biomarker technologies market is expected to witness intense competition, driving companies to continually innovate and enhance their market position. 'Roche Holding AG (Switzerland)', 'Thermo Fisher Scientific Inc. (United States)', 'QIAGEN N.V. (Netherlands)', 'Bio-Rad Laboratories, Inc. (United States)', 'Agilent Technologies, Inc. (United States)', 'Illumina, Inc. (United States)', 'PerkinElmer, Inc. (United States)', 'Abbott Laboratories (United States)', 'Siemens Healthineers AG (Germany)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Merck KGaA (Germany)', 'Bio-Techne Corporation (United States)', 'BD (Becton, Dickinson and Company) (United States)', 'Myriad Genetics, Inc. (United States)', 'Hologic, Inc. (United States)', 'Bruker Corporation (United States)', 'Agendia N.V. (Netherlands)', 'Pacific Biosciences of California, Inc. (United States)', 'Genomic Health, Inc. (United States)', 'Luminex Corporation (United States)'

Biomarker technologies play a crucial role in personalized medicine by aiding in the identification and monitoring of specific biomarkers related to an individual's health condition. The growing preference for targeted therapies and precision medicine approaches drives the demand for biomarker technologies.

The biomarker technologies market is experiencing several key trends that are shaping its growth and development. Firstly, there is a growing emphasis on personalized medicine, with biomarkers playing a crucial role in identifying and monitoring specific disease biomarkers in individual patients. This trend is driven by advancements in genomics, proteomics, and molecular diagnostics, enabling the identification of unique biomarkers for precise disease diagnosis, prognosis, and treatment selection. Secondly, there is an increasing focus on non-invasive and minimally invasive biomarker testing methods, such as liquid biopsies, to reduce patient discomfort and improve diagnostic accuracy.

North America holds a significant share in the biomarker technologies market. The United States has a robust healthcare infrastructure and a strong presence of key market players. The region's advanced research and development activities, favorable government initiatives, and high healthcare expenditure contribute to its dominance in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biomarker Technologies Market

Product ID: SQMIG35H2220

$5,300
BUY NOW GET FREE SAMPLE